Dotmatics supports Umicore Corporate R&D in processing of experimental data

Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced it has been selected by Umicore Corporate Research and Development, which is part of global materials technology and recycling company Umicore, as informatics partner for its Corporate R&D (CRD) digitalization project. The strategic agreement to implement core elements of Dotmatics’ R&D innovation platform within CRD, including electronic laboratory notebook (ELN), initially covers over 200 users and is set to run over the next 5 years.

Technology is at the core of Umicore’s success as the Company applies its unique expertise in materials science, chemistry, and metallurgy to offer solutions that enable customers to develop more sophisticated, sustainable, and safer products for cleaner mobility and other products that are essential in everyday life.

At Umicore, we use the power of technology, innovation, and data to develop materials for a better life. Our forward-looking approach and R&D digitalization project with the Dotmatics Platform will strengthen our world-class in-house expertise in metallurgy, chemistry and material science, allowing our Corporate R&D scientists to get the most out of all their data and further speed up innovation and process technologies.”

 Yves Van Rompaey, SVP, Corporate Research & Development of Umicore

Dotmatics’ platform was selected to give Umicore CRD scientists access to their data while reducing IT complexity through data standardization. Using highly configurable role-based workflows, researchers will be able to capture key scientific and operational data from design of experiments and resource planning through to executing lab activities, all with high fidelity in an Experiment Management System (EMS). The set of high-quality FAIR data (findable, accessible, interoperable, and reusable) can be analyzed to gain deep scientific insights that better inform R&D decision making. Umicore CRD scientists will have the ability to share results efficiently, avoid unnecessary rework, and streamline projects through knowledge re-use.

We’re thrilled to have been selected by Umicore Corporate R&D for their transformational digitization projectThe impact of the data-driven scientific research that companies like Umicore are leading cannot be understated — it will fuel the materials innovation key to making the world a healthier, cleaner, safer place to live.”

Mike McKee, President, Dotmatics

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dotmatics. (2022, May 18). Dotmatics supports Umicore Corporate R&D in processing of experimental data. AZoLifeSciences. Retrieved on November 21, 2024 from https://www.azolifesciences.com/news/20220518/Dotmatics-supports-Umicore-Corporate-RD-in-processing-of-experimental-data.aspx.

  • MLA

    Dotmatics. "Dotmatics supports Umicore Corporate R&D in processing of experimental data". AZoLifeSciences. 21 November 2024. <https://www.azolifesciences.com/news/20220518/Dotmatics-supports-Umicore-Corporate-RD-in-processing-of-experimental-data.aspx>.

  • Chicago

    Dotmatics. "Dotmatics supports Umicore Corporate R&D in processing of experimental data". AZoLifeSciences. https://www.azolifesciences.com/news/20220518/Dotmatics-supports-Umicore-Corporate-RD-in-processing-of-experimental-data.aspx. (accessed November 21, 2024).

  • Harvard

    Dotmatics. 2022. Dotmatics supports Umicore Corporate R&D in processing of experimental data. AZoLifeSciences, viewed 21 November 2024, https://www.azolifesciences.com/news/20220518/Dotmatics-supports-Umicore-Corporate-RD-in-processing-of-experimental-data.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Integrating Science, Software, and Data to Accelerate Antibody Discovery